⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1752169 | 1.00 | — | — | |
| SCHEMBL1751707 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7710591 | 0.97 | — | — | |
| Ethylene Glycol SCHEMBL1171278 | 0.93 | FOLH1 (0.50) | — | |
| SCHEMBL1171215 | 0.91 | FOLH1 (0.48) | — | |
| SCHEMBL1171034 | 0.91 | FOLH1 (0.48) | — | |
| Propylene Glycol SCHEMBL3087494 | 0.89 | FOLH1 (0.46) | — | |
| 1,4-Butanediol SCHEMBL6003713 | 0.89 | GPR84 (0.50) | — | |
| SCHEMBL6004016 | 0.87 | GPR84 (0.54) | — | |
| SCHEMBL3082579 | 0.87 | FOLH1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 735 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509609-B2 | Curable resin composition, resin cured film, partition wall and optical element | AGC Inc. (JP) | 2025-12-30 | — | — | US | claimed |
| WO-2025245299-A1 | METHODS OF TREATING CANCER WITH DLL3 TARGETING RADIOIMMUNOCONJUGATES | Abdera Therapeutics Inc. (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4577578-A1 | DLL3 BINDING MOLECULES AND USES THEREOF | Abdera Therapeutics Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| WO-2025063849-A2 | DIMERIC FAP TARGETING AGENTS | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) | 2025-03-27 | — | — | WO | claimed |
| US-20240392157-A1 | CURABLE RESIN COMPOSITION, RESIN CURED FILM, PARTITION WALL AND OPTICAL ELEMENT | AGC Inc. (JP) | 2024-11-28 | — | — | US | claimed |
| CN-118660924-A | Curable resin composition, resin cured film, partition wall, and optical element | ＡＧＣ株式会社 | 2024-09-17 | — | — | CN | claimed |
| CN-118561916-A | Thiazolone hapten, antigen synthesis method and application | 深圳市绿诗源生物技术有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118215676-A | Specific conjugation of antibody drug conjugates | 杭州多禧生物科技有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2024044550-A1 | DLL3 BINDING MOLECULES AND USES THEREOF | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | claimed |
| EP-2252698-A2 | ADIPATE ESTER OR THIOESTER SYNTHESIS | DSM IP Assets B.V. (NL) | 2010-11-24 | — | — | EP | claimed |
| WO-2009113853-A2 | ADIPATE (ESTER OR THIOESTER) SYNTHESIS | DSM IP ASSETS B.V. (NL) | 2009-09-17 | — | — | WO | claimed |
| US-7473796-B2 | Maytansinoid intermediates: N-alkyl- or aryldithioalkanoylalanines and N-alkanoyl- or aroylthioalkanoylalanines, e.g., N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine; optical isomers and racemic mixtures; preparations from isobutylene sulfide and acetonitrile, methyl methanethiosulfonate, etc. | IMMUNOGEN INC. (US) | 2009-01-06 | — | — | US | claimed |
| US-20070270585-A1 | Maytansinoid intermediates: N-alkyl- or aryldithioalkanoylalanines and N-alkanoyl- or aroylthioalkanoylalanines, e.g., N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine; optical isomers and racemic mixtures; preparations from isobutylene sulfide and acetonitrile, methyl methanethiosulfonate, etc. | IMMUNOGEN, INC. (US) | 2007-11-22 | — | — | US | claimed |
| US-7276497-B2 | For therapy of tumors | IMMUNOGEN INC. | 2007-10-02 | — | — | US | claimed |
| JP-2007514646-A | — | — | 2007-06-07 | — | — | JP | claimed |
| EP-1651162-A2 | IMPROVED CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS | Immunogen, Inc. (US) | 2006-05-03 | — | — | EP | claimed |
| WO-2004103272-A2 | IMPROVED CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS | IMMUNOGEN, INC. (US) | 2004-12-02 | — | — | WO | claimed |
| US-20040235840-A1 | For therapy of tumors | IMMUNOGEN, INC. | 2004-11-25 | — | — | US | claimed |
| US-4240823-A | New plant growth regulating compositions which contain derivatives of N-acyl methionine | PHILAGRO S.A. (FR) | 1980-12-23 | — | — | US | claimed |